{"id":"https://openalex.org/W2025537689","doi":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","title":"Deprenyl (selegiline) in the treatment of Parkinson's disease","display_name":"Deprenyl (selegiline) in the treatment of Parkinson's disease","alternate_titles":[],"publication_year":1983,"publication_date":"1983-07-01","ids":{"openalex":"https://openalex.org/W2025537689","doi":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","mag":"2025537689","pmid":"https://pubmed.ncbi.nlm.nih.gov/6428140"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0404.1983.tb01522.x","doi":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2025537689"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5108832600","display_name":"Walther Birkmayer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"W. BIRKMAYER","raw_affiliation_strings":["Evangelical Hospital, Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Evangelical Hospital, Vienna, Austria","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5108832600"],"corresponding_institution_ids":[],"apc_list":{"value":2490,"currency":"USD","value_usd":2490},"apc_paid":null,"fwci":0.8903,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.7119669,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"68","issue":null,"first_page":"103","last_page":"106"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10919","display_name":"Deep Brain Stimulation and Movement Disorders","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/selegiline","display_name":"selegiline","score":1.0},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.996999979019165},{"id":"https://openalex.org/keywords/levodopa","display_name":"levodopa","score":0.9679999947547913},{"id":"https://openalex.org/keywords/akinesia","display_name":"akinesia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/on-off-phenomenon","display_name":"on-off phenomenon","score":0.824999988079071},{"id":"https://openalex.org/keywords/rigidity","display_name":"rigidity","score":0.7009999752044678},{"id":"https://openalex.org/keywords/levodopa-dose-reduction","display_name":"levodopa dose reduction","score":0.8320000171661377},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.7670000195503235},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.6370000243186951}],"concepts":[{"id":"https://openalex.org/C2776134090","wikidata":"https://www.wikidata.org/wiki/Q47495783","display_name":"Selegiline","level":4,"score":0.9817429780960083},{"id":"https://openalex.org/C2780304432","wikidata":"https://www.wikidata.org/wiki/Q300989","display_name":"Levodopa","level":4,"score":0.896048367023468},{"id":"https://openalex.org/C2908591018","wikidata":"https://www.wikidata.org/wiki/Q4795512","display_name":"Decarboxylase inhibitor","level":5,"score":0.7020165920257568},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.6939220428466797},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6330631971359253},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5326359272003174},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.49990415573120117},{"id":"https://openalex.org/C2781249495","wikidata":"https://www.wikidata.org/wiki/Q420685","display_name":"Rasagiline","level":4,"score":0.4399169981479645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39309102296829224},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3602524995803833}],"mesh":[{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007980","descriptor_name":"Levodopa","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008996","descriptor_name":"Monoamine Oxidase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010043","descriptor_name":"Outcome and Process Assessment, Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010300","descriptor_name":"Parkinson Disease","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D010627","descriptor_name":"Phenethylamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D012642","descriptor_name":"Selegiline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0404.1983.tb01522.x","doi":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0404.1983.tb01522.x","pdf_url":null,"source":{"id":"https://openalex.org/S66034498","display_name":"Acta Neurologica Scandinavica","issn_l":"0001-6314","issn":["0001-6314","1600-0404"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","jufo-1","ki-jl-1","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta Neurologica Scandinavica","raw_type":"journal-article"},{"id":"pmid:6428140","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6428140","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta neurologica Scandinavica. Supplementum","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W175006040","https://openalex.org/W1981609060","https://openalex.org/W2067192352","https://openalex.org/W2117053539","https://openalex.org/W2198632085","https://openalex.org/W2274535321","https://openalex.org/W2413207710","https://openalex.org/W4233738969"],"related_works":["https://openalex.org/W2027136741","https://openalex.org/W2404543081","https://openalex.org/W1976580371","https://openalex.org/W2054286586","https://openalex.org/W2059297555","https://openalex.org/W2103120760","https://openalex.org/W111198057","https://openalex.org/W2081251225","https://openalex.org/W2008257004","https://openalex.org/W2068894178"],"abstract_inverted_index":{"Deprenyl":[0],"combined":[1,57],"with":[2,56],"levodopa":[3,58],"and":[4,33,47],"a":[5],"peripheral":[6],"decarboxylase":[7],"inhibitor":[8],"is":[9,21,45,67],"of":[10,16,26,31,42,64,75],"therapeutic":[11],"value":[12],"in":[13],"the":[14,24,72],"treatment":[15],"Parkinson's":[17],"disease.":[18],"This":[19],"conclusion":[20],"substantiated":[22],"by":[23],"improvement":[25],"akinesia,":[27],"on-off":[28],"phases,":[29],"fluctuations":[30],"disability":[32],"rigidity.":[34],"Levodopa":[35],"doses":[36],"can":[37],"be":[38],"reduced.":[39],"The":[40,60],"onset":[41],"adverse":[43],"reactions":[44],"later":[46],"side-effects":[48],"are":[49],"even":[50],"milder":[51],"when":[52],"compared":[53],"to":[54,70],"those":[55],"treatment.":[59],"most":[61],"significant":[62],"effect":[63],"deprenyl,":[65],"however,":[66],"its":[68],"ability":[69],"prolong":[71],"life":[73],"expectancy":[74],"parkinsonian":[76],"patients.":[77]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2025537689","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
